122 related articles for article (PubMed ID: 11255266)
1. The microsomal epoxide hydrolase Tyr113His polymorphism: association with risk of ovarian cancer.
Spurdle AB; Purdie DM; Webb PM; Chen X; Green A; Chenevix-Trench G
Mol Carcinog; 2001 Jan; 30(1):71-8. PubMed ID: 11255266
[TBL] [Abstract][Full Text] [Related]
2. Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer.
Lancaster JM; Brownlee HA; Bell DA; Futreal PA; Marks JR; Berchuck A; Wiseman RW; Taylor JA
Mol Carcinog; 1996 Nov; 17(3):160-2. PubMed ID: 8944076
[TBL] [Abstract][Full Text] [Related]
3. The prohibitin 3' untranslated region polymorphism is not associated with risk of ovarian cancer.
Spurdle AB; Purdie DM; Chen X; Chenevix-Trench G
Gynecol Oncol; 2003 Jul; 90(1):145-9. PubMed ID: 12821355
[TBL] [Abstract][Full Text] [Related]
4. Microsomal epoxide hydrolase polymorphism and susceptibility to ovarian cancer.
Baxter SW; Choong DY; Campbell IG
Cancer Lett; 2002 Mar; 177(1):75-81. PubMed ID: 11809533
[TBL] [Abstract][Full Text] [Related]
5. No significant association between progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of ovarian cancer.
Spurdle AB; Webb PM; Purdie DM; Chen X; Green A; Chenevix-Trench G
Carcinogenesis; 2001 May; 22(5):717-21. PubMed ID: 11323389
[TBL] [Abstract][Full Text] [Related]
6. A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk.
Spurdle AB; Chang JH; Byrnes GB; Chen X; Dite GS; McCredie MR; Giles GG; Southey MC; Chenevix-Trench G; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):769-74. PubMed ID: 17416769
[TBL] [Abstract][Full Text] [Related]
7. Epoxide hydrolase Tyr113His polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma in population of North China.
Zhang JH; Jin X; Li Y; Wang R; Guo W; Wang N; Wen DG; Chen ZF; Kuang G; Wei LZ; Wang SJ
World J Gastroenterol; 2003 Dec; 9(12):2654-7. PubMed ID: 14669306
[TBL] [Abstract][Full Text] [Related]
8. Role of genetic polymorphism of glutathione-S-transferase T1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma.
Tiemersma EW; Omer RE; Bunschoten A; van't Veer P; Kok FJ; Idris MO; Kadaru AM; Fedail SS; Kampman E
Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):785-91. PubMed ID: 11440964
[TBL] [Abstract][Full Text] [Related]
9. Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer.
Harrison DJ; Hubbard AL; MacMillan J; Wyllie AH; Smith CA
Br J Cancer; 1999 Jan; 79(1):168-71. PubMed ID: 10408710
[TBL] [Abstract][Full Text] [Related]
10. A polymorphism in the gene for microsomal epoxide hydrolase is associated with pre-eclampsia.
Zusterzeel PL; Peters WH; Visser W; Hermsen KJ; Roelofs HM; Steegers EA
J Med Genet; 2001 Apr; 38(4):234-7. PubMed ID: 11283205
[TBL] [Abstract][Full Text] [Related]
11. Microsomal epoxide hydrolase polymorphism and risk of spontaneous abortion.
Wang X; Wang M; Niu T; Chen C; Xu X
Epidemiology; 1998 Sep; 9(5):540-4. PubMed ID: 9730034
[TBL] [Abstract][Full Text] [Related]
12. The Tyr113His polymorphism in exon 3 of the microsomal epoxide hydrolase gene is a risk factor for perinatal mortality.
Raijmakers MT; de Galan-Roosen TE; Schilders GW; Merkus JM; Steegers EA; Peters WH
Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1056-60. PubMed ID: 15488121
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype.
Spurdle AB; Webb PM; Purdie DM; Chen X; Green A; Chenevix-Trench G
Carcinogenesis; 2001 Jan; 22(1):67-72. PubMed ID: 11159743
[TBL] [Abstract][Full Text] [Related]
14. Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squamous cell esophageal cancer.
Jain M; Tilak AR; Upadhyay R; Kumar A; Mittal B
Toxicol Appl Pharmacol; 2008 Jul; 230(2):247-51. PubMed ID: 18406439
[TBL] [Abstract][Full Text] [Related]
15. Association of microsomal epoxide hydrolase gene polymorphism and pre-eclampsia in Turkish women.
Pinarbasi E; Percin FE; Yilmaz M; Akgun E; Cetin M; Cetin A
J Obstet Gynaecol Res; 2007 Feb; 33(1):32-7. PubMed ID: 17212663
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
Srivastava DS; Mandhani A; Mittal RD
Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the microsomal epoxide hydrolase gene: role in lung cancer susceptibility and prognosis.
Erkisi Z; Yaylim-Eraltan I; Turna A; Görmüs U; Camlica H; Isbir T
Tumori; 2010; 96(5):756-63. PubMed ID: 21302624
[TBL] [Abstract][Full Text] [Related]
18. Association between lung cancer and microsomal epoxide hydrolase genotypes.
Benhamou S; Reinikainen M; Bouchardy C; Dayer P; Hirvonen A
Cancer Res; 1998 Dec; 58(23):5291-3. PubMed ID: 9850050
[TBL] [Abstract][Full Text] [Related]
19. [Relation Between microsomal epoxide hydrolase polymorphism and susceptibility to ovarian epithelial cancer].
Kang S; Duan LH; Li Y; Song JF; Zhang JH
Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):556-7. PubMed ID: 15363360
[No Abstract] [Full Text] [Related]
20. Microsomal epoxide hydrolase polymorphisms, cigarette smoking and prostate cancer risk in the Slovak population.
Sivonova MK; Dobrota D; Matakova T; Dusenka R; Grobarcikova S; Habala V; Salagovic J; Tajtakova M; Pidanicova A; Valansky L; Lachvacs L; Kliment J; Nagy V; Kliment J
Neoplasma; 2012; 59(1):79-84. PubMed ID: 22103900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
